BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34469585)

  • 1. Pro-tumoral behavior of omental adipocyte-derived fibroblasts in tumor microenvironment at the metastatic site of ovarian cancer.
    Iyoshi S; Yoshihara M; Nakamura K; Sugiyama M; Koya Y; Kitami K; Uno K; Mogi K; Tano S; Tomita H; Kajiwara K; Taki M; Yamaguchi S; Nawa A; Kajiyama H
    Int J Cancer; 2021 Dec; 149(11):1961-1972. PubMed ID: 34469585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metastatic phenotype shift toward myofibroblast of adipose-derived mesenchymal stem cells promotes ovarian cancer progression.
    Tang H; Chu Y; Huang Z; Cai J; Wang Z
    Carcinogenesis; 2020 Apr; 41(2):182-193. PubMed ID: 31046126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the bi-directional cross-talk between ovarian cancer cells and adipocytes by SPARC.
    John B; Naczki C; Patel C; Ghoneum A; Qasem S; Salih Z; Said N
    Oncogene; 2019 May; 38(22):4366-4383. PubMed ID: 30765860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth.
    Nieman KM; Kenny HA; Penicka CV; Ladanyi A; Buell-Gutbrod R; Zillhardt MR; Romero IL; Carey MS; Mills GB; Hotamisligil GS; Yamada SD; Peter ME; Gwin K; Lengyel E
    Nat Med; 2011 Oct; 17(11):1498-503. PubMed ID: 22037646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes from Human Omental Adipose-Derived Mesenchymal Stem Cells Secreted into Ascites Promote Peritoneal Metastasis of Epithelial Ovarian Cancer.
    Qu Q; Liu L; Cui Y; Chen Y; Wang Y; Wang Y
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis.
    Ladanyi A; Mukherjee A; Kenny HA; Johnson A; Mitra AK; Sundaresan S; Nieman KM; Pascual G; Benitah SA; Montag A; Yamada SD; Abumrad NA; Lengyel E
    Oncogene; 2018 Apr; 37(17):2285-2301. PubMed ID: 29398710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian cancer-associated mesothelial cells induce acquired platinum-resistance in peritoneal metastasis via the FN1/Akt signaling pathway.
    Yoshihara M; Kajiyama H; Yokoi A; Sugiyama M; Koya Y; Yamakita Y; Liu W; Nakamura K; Moriyama Y; Yasui H; Suzuki S; Yamamoto Y; Ricciardelli C; Nawa A; Shibata K; Kikkawa F
    Int J Cancer; 2020 Apr; 146(8):2268-2280. PubMed ID: 31904865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertonicity induces mitochondrial extracellular vesicles (MEVs) that activate TNF-α and β-catenin signaling to promote adipocyte dedifferentiation.
    Liu G; Wang Y; Pan Y; Tian L; Choi MH; Wang L; Kim JY; Zhang J; Cheng SH; Zhang L
    Stem Cell Res Ther; 2023 Dec; 14(1):333. PubMed ID: 38115136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour-derived exosomal piR-25783 promotes omental metastasis of ovarian carcinoma by inducing the fibroblast to myofibroblast transition.
    Li G; Yi X; Du S; Gong L; Wu Q; Cai J; Sun S; Cao Y; Chen L; Xu L; Wang Z
    Oncogene; 2023 Feb; 42(6):421-433. PubMed ID: 36482201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipocyte-derived fibroblasts promote tumor progression and contribute to the desmoplastic reaction in breast cancer.
    Bochet L; Lehuédé C; Dauvillier S; Wang YY; Dirat B; Laurent V; Dray C; Guiet R; Maridonneau-Parini I; Le Gonidec S; Couderc B; Escourrou G; Valet P; Muller C
    Cancer Res; 2013 Sep; 73(18):5657-68. PubMed ID: 23903958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer.
    Yamamura S; Matsumura N; Mandai M; Huang Z; Oura T; Baba T; Hamanishi J; Yamaguchi K; Kang HS; Okamoto T; Abiko K; Mori S; Murphy SK; Konishi I
    Int J Cancer; 2012 Jan; 130(1):20-8. PubMed ID: 21503873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human omental-derived adipose stem cells increase ovarian cancer proliferation, migration, and chemoresistance.
    Nowicka A; Marini FC; Solley TN; Elizondo PB; Zhang Y; Sharp HJ; Broaddus R; Kolonin M; Mok SC; Thompson MS; Woodward WA; Lu K; Salimian B; Nagrath D; Klopp AH
    PLoS One; 2013; 8(12):e81859. PubMed ID: 24312594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis.
    Mitra AK; Chiang CY; Tiwari P; Tomar S; Watters KM; Peter ME; Lengyel E
    Oncogene; 2015 Nov; 34(48):5923-32. PubMed ID: 25798837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WNT signaling inducing activity in ascites predicts poor outcome in ovarian cancer.
    Kotrbová A; Ovesná P; Gybel' T; Radaszkiewicz T; Bednaříková M; Hausnerová J; Jandáková E; Minář L; Crha I; Weinberger V; Záveský L; Bryja V; Pospíchalová V
    Theranostics; 2020; 10(2):537-552. PubMed ID: 31903136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does TP53 mutation promote ovarian cancer metastasis to omentum by regulating lipid metabolism?
    Hu J; Liu Z; Wang X
    Med Hypotheses; 2013 Oct; 81(4):515-20. PubMed ID: 23880140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated mesothelial cell-derived ANGPTL4 and STC1 promote the early steps of ovarian cancer metastasis.
    Bajwa P; Kordylewicz K; Bilecz A; Lastra RR; Wroblewski K; Rinkevich Y; Lengyel E; Kenny HA
    JCI Insight; 2023 Mar; 8(6):. PubMed ID: 36795484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Lactic Acidosis of the Tumor Microenvironment Drives Adipocyte-to-Myofibroblast Transition Fueling the Generation of Cancer-Associated Fibroblasts.
    Andreucci E; Fioretto BS; Rosa I; Matucci-Cerinic M; Biagioni A; Romano E; Calorini L; Manetti M
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
    Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
    Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer.
    Rynne-Vidal A; Au-Yeung CL; Jiménez-Heffernan JA; Pérez-Lozano ML; Cremades-Jimeno L; Bárcena C; Cristóbal-García I; Fernández-Chacón C; Yeung TL; Mok SC; Sandoval P; López-Cabrera M
    J Pathol; 2017 Jun; 242(2):140-151. PubMed ID: 28247413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipocytes contribute to tumor progression and invasion of peritoneal metastasis by interacting with gastric cancer cells as cancer associated fibroblasts.
    Hamabe-Horiike T; Harada SI; Yoshida K; Kinoshita J; Yamaguchi T; Fushida S
    Cancer Rep (Hoboken); 2023 Jan; 6(1):e1647. PubMed ID: 35691615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.